Mark H Paul, president of the Neurovascular division at Stryker, spoke to NeuroNews, for a launch of a new column titled MedTech Insights.
Paul, who has over three decades of experience in the “less invasive” medical device industry and leads teams in more than 60 countries around the world, talks about neurovascular treatment currently being in its “heyday”. He pinpoints robotics, AI and progress in imaging as the next drivers of transformation in the neurovascular space.
This is an excerpt from the interview. An article covering the full interview will be released online in November 2020 and in our next newspaper edition.
